Vicapsys Life Sciences (Vicapsys Life Sciences) EBIT per Share : $-0.02 (TTM As of Sep. 2023)

View and export this data going back to . Start your Free Trial

What is Vicapsys Life Sciences EBIT per Share?

Vicapsys Life Sciences's EBIT per Share for the three months ended in Sep. 2023 was $-0.01. Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.02.

During the past 3 years, the average EBIT per Share Growth Rate was 38.70% per year. During the past 5 years, the average EBIT per Share Growth Rate was 72.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Vicapsys Life Sciences's EBIT per Share or its related term are showing as below:

VICP' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 38.7 Med: 81.5 Max: 83.1
Current: 38.7

During the past 6 years, the highest 3-Year average EBIT per Share Growth Rate of Vicapsys Life Sciences was 83.10% per year. The lowest was 38.70% per year. And the median was 81.50% per year.

VICP's 3-Year EBIT Growth Rate is ranked better than
87.28% of 1305 companies
in the Biotechnology industry
Industry Median: 3.6 vs VICP: 38.70

Vicapsys Life Sciences's EBIT for the three months ended in Sep. 2023 was $-0.23 Mil.

Vicapsys Life Sciences EBIT per Share Historical Data

The historical data trend for Vicapsys Life Sciences's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vicapsys Life Sciences EBIT per Share Chart

Vicapsys Life Sciences Annual Data

Trend

Dec08

Dec09

Dec19

Dec20

Dec21

Dec22

EBIT per Share

Get a 7-Day Free Trial

-3.89

-0.09

-0.04

-0.02

Vicapsys Life Sciences Quarterly Data
	Jun10	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
EBIT per Share	Get a 7-Day Free Trial															-0.01	-0.01	-0.01	-	-0.01

Vicapsys Life Sciences EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Vicapsys Life Sciences's EBIT per Share for the fiscal year that ended in Dec. 2022 is calculated as

	EBIT per Share		(A: Dec. 2022 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-0.645	/	30.578
=	-0.02

Vicapsys Life Sciences's EBIT per Share for the quarter that ended in Sep. 2023 is calculated as

	EBIT per Share		(Q: Sep. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-0.23	/	34.405
=	-0.01

EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.02

Vicapsys Life Sciences (OTCPK:VICP) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Vicapsys Life Sciences EBIT per Share Related Terms

Thank you for viewing the detailed overview of Vicapsys Life Sciences's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Vicapsys Life Sciences (Vicapsys Life Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vicapsys Life Sciences Inc (OTCPK:VICP) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

7778 Mcginnis Ferry Road, Suite 270, Suwanee, GA, USA, 30024

Website

https://www.vicapsys.com

Vicapsys Life Sciences Inc is a biotech company that is engaged in commercializing implantable medical products that incorporate VICAPSYN, inducing a zone of immuno-protection around devices and cells implanted in the human body. The product name VICAPSYN is the company's line of proprietary product candidates that is applied to transplantation therapies and related stem-cell applications in the transplantation field.

Executives

Moore Bobby M Jr	10 percent owner	4125 S.B. MERRION ROAD, LAKELAND FL 33810
Robert Grammen	10 percent owner	9180 GALLENA COURT, NAPLES FL 34109
Michael Yurkowski	director	1505 ELM STREET, #1504, DALLAS TX 75201
William P. Esping	10 percent owner	2828 ROUTH STREET, SUITE 500, DALLAS TX 75201
Rodger Rees	director	C/O BONDS.COM GROUP, INC., 1515 SOUTH FEDERAL HIGHWAY, SUITE 212, BOCA RATON FL 33432
Mark Feldmesser	director	641 UNIVERSITY BLVE, JUPITER FL 33458
Federico Pier	director	1004 PLUM DRIVE, IRVING TX 75063
Ryan Seddon	director, 10 percent owner	8120 BELVEDERE ROAD, SUITE 4, WEST PALM BEACH FL 33411

Vicapsys Life Sciences (Vicapsys Life Sciences) Headlines

From GuruFocus

ViCapsys Life Sciences Appoints Federico Pier as Permanent Chief Executive Officer

By ACCESSWIRE ACCESSWIRE • 04-13-2022